evidence answer

Is Resveratrol Sleep Meta-Analysis safe?

Updated August 2026

Quick Answer

Resveratrol Sleep Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Resveratrol significantly reduced pain scores (WMD: -2.841, 95% CI: -5.631 to -0.050, p = 0.046), pain VAS scores (WMD: -7.585, 95% CI: -12.912 to -2.257, p = 0.005), PPI scores (WMD: -8.563, 95% CI: -12.866 to -4.261, p Conclusion Resveratrol may improve pain and bone metabolism (CTX) in postmenopausal women but did not affect other examined outcomes.

Key Takeaways

  • 01Resveratrol significantly reduced pain scores (WMD: -2.841, 95% CI: -5.631 to -0.050, p = 0.046), pain VAS scores (WMD: -7.585, 95% CI: -12.912 to -2.257, p = 0.005), PPI scores (WMD: -8.563, 95% CI: -12.866 to -4.261, p Conclusion Resveratrol may improve pain and bone metabolism (CTX) in postmenopausal women but did not affect other examined outcomes. [Wu W (2025)]
  • 02Objectives This meta-analysis aims to systematically evaluate the impact of resveratrol on postmenopausal women. [Wu W (2025)]
  • 03Methods We searched seven electronic databases and conducted meta-analyses using Stata 12.0. [Wu W (2025)]
The current Migaku evidence database contains 1 reusable source document for Resveratrol Sleep Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Resveratrol significantly reduced pain scores (WMD: -2.841, 95% CI: -5.631 to -0.050, p = 0.046), pain VAS scores (WMD: -7.585, 95% CI: -12.912 to -2.257, p = 0.005), PPI scores (WMD: -8.563, 95% CI: -12.866 to -4.261, p Conclusion Resveratrol may improve pain and bone metabolism (CTX) in postmenopausal women but did not affect other examined outcomes. [Wu W (2025); evidence level 1] - Objectives This meta-analysis aims to systematically evaluate the impact of resveratrol on postmenopausal women. [Wu W (2025); evidence level 1] - Methods We searched seven electronic databases and conducted meta-analyses using Stata 12.0. [Wu W (2025); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Learn next

Keep learning from this answer

SupplementGlycineNon-essential amino acid that cools core body temperature and deepens slow-wave sleep — remarkab...SupplementBerberinePlant alkaloid with clinical evidence rivalling metformin for blood glucose control and lipid ma...GuideResveratrol Sleep Meta-analysis: What the Evidence SaysResveratrol Sleep Meta-analysis has 1 source documents in the current Migaku evidence database....GuideSaffron Sleep Latency Meta-analysis: What the Evidence SaysSaffron Sleep Latency Meta-analysis has 2 source documents in the current Migaku evidence databa...GuideMagnesium Sleep Maintenance Meta-analysis: What the Evidence SaysMagnesium Sleep Maintenance Meta-analysis has 2 source documents in the current Migaku evidence...GuideMelatonin Sleep Jet Lag Meta-analysis: What the Evidence SaysMelatonin Sleep Jet Lag Meta-analysis has 2 source documents in the current Migaku evidence data...CompareNMN vs ResveratrolNMN acts as the primary 'fuel' that raises cellular NAD+ levels. Resveratrol acts as the 'accele...DataResveratrol Sleep Meta-Analysis Evidence TableStructured evidence table for Resveratrol Sleep Meta-Analysis, generated from 1 reusable source...

Sources

  1. Effects of resveratrol on postmenopausal women: a systematic review and meta-analysis.